HomeSUNPHARMA • NSE
add
Sun Pharmaceutical Industries Ltd
Previous close
₹1,898.40
Day range
₹1,915.25 - ₹1,959.30
Year range
₹1,068.35 - ₹1,959.30
Market cap
4.68T INR
Avg Volume
1.87M
P/E ratio
44.90
Dividend yield
0.69%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 126.53B | 5.96% |
Operating expense | 69.74B | 7.23% |
Net income | 28.36B | 40.20% |
Net profit margin | 22.41 | 32.29% |
Earnings per share | 11.80 | 24.37% |
EBITDA | 35.92B | 10.02% |
Effective tax rate | 16.18% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 190.90B | 26.17% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 671.06B | — |
Shares outstanding | 2.40B | — |
Price to book | 7.15 | — |
Return on assets | — | — |
Return on capital | 10.67% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 28.36B | 40.20% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia
Founded
1983
Headquarters
Website
Employees
43,000
